These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25066142)

  • 41. Vancomycin dosing and monitoring 2 years after the guidelines.
    Lomaestro BM
    Expert Rev Anti Infect Ther; 2011 Jun; 9(6):657-67. PubMed ID: 21692671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
    Brown DL; Lalla CD; Masselink AJ
    Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
    Denetclaw TH; Dowling TC; Steinke D
    Ann Pharmacother; 2013 Dec; 47(12):1611-7. PubMed ID: 24259632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vancomycin administration and monitoring reappraisal.
    Saunders NJ
    J Antimicrob Chemother; 1995 Aug; 36(2):279-82. PubMed ID: 8522457
    [No Abstract]   [Full Text] [Related]  

  • 45. Vancomycin dosing in children: what is the question?
    Cole TS; Riordan A
    Arch Dis Child; 2013 Dec; 98(12):994-7. PubMed ID: 23956256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Teicoplanin.
    Salaria M
    Indian Pediatr; 2001 Apr; 38(4):372-5. PubMed ID: 11313506
    [No Abstract]   [Full Text] [Related]  

  • 47. Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.
    Neuman G; Nulman I; Adeli K; Koren G; Colantonio DA; Helldén A
    J Clin Pharmacol; 2014 Jul; 54(7):785-91. PubMed ID: 24596064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comments on decreased mortality in patients prescribed vancomycin after implementation of an antimicrobial stewardship program.
    Safiri S; Ayubi E
    Am J Infect Control; 2018 Apr; 46(4):477. PubMed ID: 29329920
    [No Abstract]   [Full Text] [Related]  

  • 49. Weight-based loading of vancomycin in patients on hemodialysis.
    Brown M; Polisetty R; Gracely EJ; Cuhaci B; Schlecht HP
    Clin Infect Dis; 2011 Jul; 53(2):164-6. PubMed ID: 21690623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections.
    Bafeltowska JJ; Buszman E; Mandat KM; Hawranek JK
    Surg Neurol; 2004 Aug; 62(2):142-50; discussion 150. PubMed ID: 15261509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased mortality in patients prescribed vancomycin after implementation of an antimicrobial stewardship program.
    Conway E; Sellick J; Mergenhagen K
    Am J Infect Control; 2018 Apr; 46(4):477-478. PubMed ID: 29592833
    [No Abstract]   [Full Text] [Related]  

  • 52. Vancomycin use and antimicrobial resistance in hemodialysis centers.
    Tokars JI
    Am J Kidney Dis; 1998 Sep; 32(3):521-3. PubMed ID: 9740174
    [No Abstract]   [Full Text] [Related]  

  • 53. Therapeutic drug monitoring of gentamicin: evaluation of five nomograms for initial dosing at Al-Amiri Hospital in Kuwait.
    Al-Lanqawi Y; Capps P; Abdel-hamid M; Abulmalek K; Phillips D; Matar K; Sharma P; Thusu A
    Med Princ Pract; 2007; 16(5):348-54. PubMed ID: 17709922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.
    Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM
    J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
    Beumier M; Roberts JA; Kabtouri H; Hites M; Cotton F; Wolff F; Lipman J; Jacobs F; Vincent JL; Taccone FS
    J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
    De Bock V; Verbeelen D; Maes V; Sennesael J
    Nephrol Dial Transplant; 1989; 4(7):635-9. PubMed ID: 2510061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
    Kitzis MD; Goldstein FW
    Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.